GLP1R and pulmonary fibrosis: However, it was reported that vildagliptin ameliorated the lung injury in a model of pulmonary fibrosis through a mechanism independent of GLP-1 [12]; therefore, further studies are encouraged to explore this action of vildagliptin in the model of renal injury following hepatic I/R.